immune responses to type 1 antigens and to B cell mitogens that could effectively stimulate cells of both CBA/N and C3H/HeJ type (4) . Since similar results were obtained using C3H/HeN mice as the breeding partners, it appeared that the LPSa-determined defect of the C3H/HeJ mice was not required to produce these synergistic defects. We have now established two inbred lines of mice that express this synergistic immunological defect and we report here the immunological features of these mice. These strains possess the xid trait on either the C3H/ HeN or C3H/HeJ backgrounds and are designated C3.CBA/N and C3J.xid, respectively. Spleen cells from mice of both strains do not respond in vitro to any B cell mitogen we have examined, including lipopolysaccharide (LPS), ~ Nocardia water-soluble mitogen (NWSM), and antiimmunoglobulin (anti-Ig) antibody conjugated to Sepharose beads. Additionally, their in vitro antibody response to the type 1 antigen trinitrophenyi-Brucella abortus (TNP-BA) is either undetectable or 10-100 times lower than that of cells from parental strains. Responsiveness of spleen cells from these defective strains cannot be enhanced by a T cell factor-rich supernatant, whereas responsiveness of cells from both C3H and CBA/N strains can be enhanced. F~ female mice resulting from the mating of C3.CBA/N and C3J.xid exhibit the same profound immunologic defect as their parents, suggesting that the genetic basis for their defects is identical and noncomplementary.
Materials and Methods
Mice. C3J.xid mice were obtained from original crosses of CBA/N (xid]xid) females (obtained from the Division of Research Services, National Institutes of Health) with C3H/HeJ (+/Y) males (The Jackson Laboratory, Bar Harbor, ME). Fl females resulting from this cross, which are heterozygous at the xid locus (+/xid), were crossed to C3H/HeJ males. The male offspring of this cross were immunized with TNP-aminoethylcarbamylmethyl-Ficoll (TNP-Ficoll) (20 ~g) , and their sera were tested 5 d later for the presence of anti-TNP antibodies by hemagglutination of TNP-sheep erythrocytes (TNP-SE). Mice that failed to produce anti-TNP antibody were judged to be xid/Y and were mated to C3H/HeJ females. Four additional cycles of this type were carried out. xid]Y males from the ninth backcross generation were mated to +/xid females from the eighth backcross generation. Male and female progeny from this cross that were unresponsive to TNPFicoll were mated to create an inbred strain. Tail skin from mice of the fifth intercross generation was grafted to C3H/HeJ, BALB/c, and CBA/N mice. The grafts were not rejected by C3H[HeJ mice over a 4-too period whereas BALB/c mice rejected grafts by day 10 and CBA]N mice rejected the grafts by day 21. C3.CBA/N mice were bred as follows: The xid gene was introduced into the C3H/HeN inbred mouse strain by repeated cycles of backcrossing. The initial cross consisted of mating a CBA/N female, which is homozygous for the xid gene, to a C3H/HeN male. The female progeny from this mating were heterozygous for the xid gene and the males, hemizygous. One of the male offspring was backcrossed to a CBA/N female. The progeny from the backcross mating were either homozygous, in case of the females, or hemizygous, for the males. The second cycle consisted of mating a homozygous female, now designated as C3.CBA/N, to a C3H/HeN male. A male offspring from this mating was backcrossed to his mother to produce a homozygous female that was bred to a C3H/HeN male. This procedure was repeated for the subsequent cycles that currently continue. The N equivalents for the mice used in this study vary from 5 to 7.
Antibody-dependent Cell-mediated Cytotoxicity. Antiserum to chicken erythrocyte (CE) was prepared by injecting a 10% suspension of CE into New Zealand rabbits. A pool of sera from three rabbits was used that had a hemagglutinin titer of 1.6 × 10 -4. CE target cells (107) were incubated for 1 h at 37°C with 150 ~tCi of sodium-51chromate (5'Cr) (sp act 264 mCi/mg) (New England Nuclear Boston, MA) and washed three times before use. Spleen cells from C3J.xid, C3H/HeJ, and CBA/N mice were used as effector cells. 2.5 × 106 effector cells in 1 ml RPMI 1640 medium supplemented with 10% fetal calf serum (Flow Laboratories, Inc., McLean, VA) were mixed with 105 labeled CE in 0.1 ml of heatinactivated rabbit anti-CE antiserum, diluted 1:3,200, and then incubated at 37 °C for 18 h. Effector cells cultured with 5~Cr-labeled CE in the presence of normal rabbit serum at the same dilution with 5~Cr-labeled CE alone in the absence of serum served as controls. Total radioactivity was taken to be equivalent to the radioactivity released by incubating the target cells with 1% Triton X-100. The tubes were incubated in an upright position at 37°C in an atmosphere of 5% CO2. They were then centrifuged for 10 min at 160 g and the radioactivity of the supernatant was determined in a gamma counter.
Cytotoxicity was expressed as percent specific release of label as follows: Percent cytotoxicity = [(cpmAb --cpmsR)/(cpmT --CpmsR)] × 100, where cpmAb is the counts in supernatant of the tubes with rabbit serum (normal or anti-CE), CpmsR is the spontaneous release of counts in the control tubes with nonimmune serum, and cpmT is the total radioactivity released by treatment with Triton X-100.
Antigens, Mitogens, and T Cell Factors. TNP-Ficoll and TNP-BA were prepared as previously described (5, 6) . LPS from Escherichia coli 0111 :B4, prepared according to the Boivin procedure, was purchased from Difco Laboratories, Inc., Detroit, MI. Since this mitogen contains lipoprotein, it is able to stimulate proliferative and plaque-forming cell (PFC) responses by C3H/HeJ spleen cells. NWSM was prepared according to the technique of Clorbovn et al. (7) . Concanavalin A (Con A) was obtained from Pharmacia Fine Chemicals, Piscataway, NJ. Polymerized flagellin (POL) from Staphylococcus adelaide and type III pneumococcal polysaccharide (SIII) were a gift from Dr. P. Baker, Laboratory of Microbial Immunity, NIH. Supernatant fluid from the EL4 thymoma line, stimulated with phorbol myristic acetate (PMA), was collected as previously described (8) . Goat antimouse IgM and IgD antibodies were purified and conjugated to Sepharose beads as previously described (9, 10) .
In Cell Separation Procedures. Mice received injections of 0.04 ml of rabbit anti-mouse thymocyte antiserum (ATS) (Microbiological Associates, Walkersville, MD). 48 h later, spleen cell suspensions were prepared and treated with monoclonal anti-mouse Thy-l.2 (Becton, Dickinson & Co., Sunnyvale, CA) and guinea pig complement and then resuspended to 107 cells/ml in RPMI supplemented with 10% FCS. 5.0 ml of these cells, at 107/ml, were incubated for an additional 1 h at room temperature on petri dishes coated with goat anti-mouse Ig antibody; adherent cells were recovered by detachment with a rubber policeman. Nonadherent cells (null cells) were found to contain <2% surface Ig (sIg) ÷ or Thy-l.2 ÷ cells, as evaluated by analysis of cells stained with fluorescein isothiocyanate (FITC)-Iabeled monoclonal anti-IgM antibody or FITC-labeled anti-Thy-l.2 antibody, using fluorescence microscopy.
For in vivo immunization, 0.1 ml of a 1:10 dilution of TNP-BA was injected intravenously and anti-TNP PFC responses measured 5 and 7 d later. Sera was assayed for anti-T NP antibody using a radioimmunoassay as previously described (11) .
Flow Microfluorometric Analysis of slg + Cells. FITC conjugates of F(ab')2 fragments of rabbit anti-mouse IgM, goat anti-mouse IgD, and goat anti-keyhole limpet hemocyanin (KLH) were prepared as previously described (10) . FITC-conjugated anti-Thy-l.2 was prepared using a monoclonal anti-Thy-l.2 (Becton, Dickinson & Co.). Preparation of cells for staining and the method for their analysis on the FACS II (B-D FACS Systems, Becton, Dickinson & Co.) has been previously described (10) . (3) 298 ( (Table I) . This low level of responsiveness was seen at all cell densities tested varying from 2.5 x 105 to 106 per well (data not shown).
Results

In Vitro Antibody
The impaired responsiveness of cells from the C3J.xid mice does not appear to be a consequence of the presence of naturally occurring suppressor cells, since equal mixtures of these nonresponder spleen cells with C3H spleen cells did not suppress the antibody response to TNP-BA mounted by the normal spleen cell population (Table II) pletely accounted for by the proliferative responses mounted by the null cell population. The purified B cell population of these mice was essentially unresponsive to this mitogen (Fig. 1) . Previous studies using rabbit lymphocytes also (Table IV) . (17) . To determine whether the impaired responses of C3.CBA/N to TNP-BA could be enhanced by soluble factors in such supernatants, we cultured their splenic B cells with TNP-BA and EL4-derived supernatant (Table V) . Although this factor markedly enhanced PFC responsiveness of cells from CBA/N and C3H/HeN mice to type 1 antigens, it had little or no effect on C3.CBA/N cells. (Table VI) . Their spleens had on the average 30% fewer slgM ÷ cells as compared with CBA/N mice, and 60% fewer than C3H (Table VII) . As expected, the mice with the xid defect were unresponsive to TNP-Ficoll; however, all three strains responded to immunization with TNP-BA. The facilitated PFC response of both CBA/N and C3.CBA/N was lower than that of C3H mice. In another experiment, C3H, C3.CBA/N, and CBA/N mice were immunized intravenously with TNP-BA, and serum titers of anti-TNP antibody were determined (Table VIII) (Fig. 2) . These results are consistent with the increased numbers of Thy-l.2-sIg-cells found in these mice.
Inability of T Cell-derived
Flow Microfluorometric Analysis of slg + Cells in the Spleen
Lack of Complementation of the hnmune Defects in an F] Female Mouse Resulting
from the Mating of C3.CBA/N and C3J.xid. To determine whether the genetic basis for the immune defects of the C3.CBA/N and C3J.xid were similar, female progeny of a cross of these two strains were studied (Table IX) . Both the in vitro proliferative response stimulated by LPS and the in vitro antibody response to TNP-BA was impaired in the cells from these mice, suggesting that the immune defects of these two strains of mice reflect a common genetic derangement. It should be noted, however, that since individual cells express only a single X chromosome, F1 females should actually be chimeras of C3.CBA/N and C3J.xid The in vitro unresponsiveness of these mice obviously does not reflect the absence of B cells. Although this is implicit in their ability to make in vivo responses to TNP-BA and PR8, it is directly established by studies of their B cells. The percent of sIgM + cells in spleens and Peyer's patches of C3.CBA/N mice is "-,30% less than that of CBA/N mice and "-60% less than that of C3H/ HeN mice; a greater decrease in the percent of sIgM + cells was observed in the peripheral lymph nodes of these immune-defective mice. It is of particular interest that the frequency of sIgD + cells in the spleen of C3.CBA/N mice is markedly reduced, to 50% of the number of sIgM + cells. The high frequency of sIgM + sIgD-cells in these mice could reflect either the relatively large numbers of immature B cells or the presence of activated B cells that have lost sIgD. Since lymph nodes normally contain large numbers of activated B lymphocytes but have few immature B lymphocytes, the paucity of sIg + cells in lymph nodes from C3.CBA/N mice suggests that the sIgM + sIgD-spleen cells represent a largely immature rather than an activated population of B cells.
The inability of cells from C3.CBA/N mice to respond in vitro to type 1 antigens or to B cell mitogens may be a result of their inability to respond to various lymphokines that influence B cell growth, such as those present in EL4 supernatant. This suggestion is premised on the idea that for in vitro responses to type 1 and 2 antigens and to B cell mitogens, including insolubilized anti-Ig, it is not antigen-specific T cells that influence the magnitude of the response but rather T cell-derived lymphokines that are required to enhance B cell responsiveness. B. abortus functions in vitro as a type 1 antigen, but it also has been shown to stimulate antigen-specific T cells in vivo (18) . Thus, it is not surprising that in vivo immunization of normal mice with TNP-BA can stimulate responses dependent on carrier-specific T cells as well as factor-dependent responses. Our observation that C3.CBA/N and C3J.xid mice respond in vivo to the T celldependant antigen TNP-KLH suggests that the pathway dependent on carrierspecific T cells is intact in these animals. We propose that the in vivo response of C3.CBA/N mice to TNP-BA results from the action of carrier-specific T cells. Based on these observations, we propose the following model (Fig. 3) to explain the "synergistic defect" of C3.CBA/N and C3J.xid mice: C3H/HeN and C3H/ HeJ mice may have an immune defect in B cell function that is not normally detected but which in an xid mouse has a profound effect on the overall B cell response. Such mice with the xid defect lack a mature subset of Lyb5 ÷ B cells and have only Lyb5-B cells that can be activated by antigens via two alternative routes, that involving carrier-specific T cells and that involving type 1 antigens (e.g., TNP-BA, LPS) and soluble factors. In vitro, where carrier-specific T cell help is limiting, stimulation of resting Lyb5-B cells with a combination of type 1 antigen and lymphokines leads to B cell proliferation and differentiation. Since B cells from C3.CBA/N mice, however, are poorly responsive to type 1 antigens and to factors in EL4 supernatant, it would be reasonable to propose that the defect of these mice lies in the insensitivity of their Lyb5-B cells to stimulation along that pathway of activation that is available to "normal" Lyb5-cells. The pathway of factor-dependent activation of resting Lyb5-cells by type 1 antigens cannot be initiated by T cell-dependent antigens in a primary in vitro antibody response since responsiveness to this class of antigens requires the participation of a number of T cell-derived lymphokines to which Lyb5-B cells from CBA/N mice are unable to respond (19, 20) . The second pathway of activation that is available to Lyb5-B cells proceeds via interaction with a carrierspecific, major histocompatibility complex (MHC)-restricted T helper cell. This mode of activation stimulates Lyb5-cells from CBA/N mice as well as from Received for publication 1 June 1983. 
